Fig. 3From: Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovirTrend in estimated marginal mean levels of 10-year CVD riskBack to article page